We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Prescription medication — not a dietary supplement
Insulin (bodybuilding use)is a prescription (or investigational) drug, not a supplement. It is included here for reference because people research and discuss it (often used off-label) — not as a recommendation. Take it only under a qualified clinician's supervision and only as prescribed; do not source it from grey-market vendors, where identity, purity, and dosing are unverified. The evidence below reflects its clinical trials.
What the evidence says
Most Insulin (bodybuilding use) studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality meta-analyses and randomised trials published 1987–2019 with a typical study size of 173 participants.
Based on 6 studies · 1 meta-analysis · 1 RCT · 180 total participants
Confidence
ModerateBy outcome
Insulin (bodybuilding use) has an evidence score of 3.2/10 — emerging evidence based on 6 indexed studies, including 1 meta-analysis. Insulin is a life-saving prescription hormone for diabetes — and, used illicitly by bodybuilders as an off-label 'anabolic,' one of the most dangerous performance drugs in existence. The theory is nutrient partitioning: insulin drives glucose and amino acids into muscle and suppresses muscle-protein breakdown. But there is NO controlled evidence that insulin builds muscle or improves performance in healthy, non-diabetic athletes — and a non-diabetic who injects it risks profound, sometimes FATAL hypoglycemia (coma, seizures, brain injury, death), plus fat gain. This is a harm-reduction reference documenting a popular, deadly misuse, NOT a recommendation and NOT a dietary supplement. Representative study: PMID 26404065.
The commonly studied dose of Insulin (bodybuilding use) is There is NO endorsed bodybuilding dose — this entry does not provide a protocol, because using insulin without diabetes can cause fatal hypoglycemia and there is no evidence it builds muscle in healthy people. For medical context only: insulin is a prescription drug dosed by a clinician for diabetes, individually titrated to blood glucose and measured in international units (IU). Any non-medical, performance-driven use is illicit and dangerous, and we deliberately give no dose, timing, or 'carb-with-insulin' scheme.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Mecasermin (IGF-1)
Mostly mechanism / observationalThe pharmaceutical-grade version of IGF-1 — an FDA/EMA-approved prescription injectable, but approved ONLY for a rare childhood growth disorder (severe primary IGF-1 deficiency / Laron syndrome), where it genuinely raises height velocity in clinical trials. It is the regulated counterpart to the grey-market igf-1-lr3 peptide bodybuilders inject, and shares the same core risks. Crucially, there is NO trial supporting its off-label use for muscle, performance, or anti-aging in healthy adults — and IGF-1's documented harms (hypoglycemia, intracranial hypertension, lymphoid/tonsillar hypertrophy, and a theoretical cancer concern because IGF-1 is mitogenic) are real. Not a dietary supplement, not a longevity drug.
Last reviewed June 2026 · evidence from 6 studies · how we score
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Insulin — anabolic/anti-catabolic hormone misused off-label by bodybuilders for nutrient partitioning
Insulin is a life-saving prescription hormone for diabetes — and, used illicitly by bodybuilders as an off-label 'anabolic,' one of the most dangerous performance drugs in existence. The theory is nutrient partitioning: insulin drives glucose and amino acids into muscle and suppresses muscle-protein breakdown. But there is NO controlled evidence that insulin builds muscle or improves performance in healthy, non-diabetic athletes — and a non-diabetic who injects it risks profound, sometimes FATAL hypoglycemia (coma, seizures, brain injury, death), plus fat gain. This is a harm-reduction reference documenting a popular, deadly misuse, NOT a recommendation and NOT a dietary supplement.
Insulin has a real but narrow anti-catabolic physiology — a systematic review/meta-analysis (Abdulla 2016) and classic forearm studies (Gelfand 1987) show it improves net muscle-protein balance mainly by suppressing protein BREAKDOWN, not by stimulating synthesis, and only permissively given adequate amino acids. Crucially, there is NO controlled evidence that exogenous insulin increases muscle, strength, or performance in healthy non-diabetic athletes, while the abuse literature documents severe, sometimes FATAL hypoglycemia (coma, seizures, ICU care) in bodybuilders who inject it, plus fat gain. The score is low: no proven performance benefit against a lethal, well-documented risk. Insulin's evidence-based role is treating diabetes, not building muscle.
Insulin is the body's master anabolic hormone — a 51-amino-acid peptide secreted by pancreatic beta cells that lowers blood glucose by driving glucose uptake into muscle and fat, stimulates glycogen and fat storage, promotes amino-acid uptake, and powerfully suppresses the breakdown of muscle protein.
As a medicine, exogenous insulin is indispensable and unambiguously beneficial: it is the foundational, life-saving treatment for type 1 diabetes and an important therapy in type 2 — that approved use is real, evidence-based, and not in dispute.
This entry is about a completely different, illicit activity: the off-label use of injected insulin by bodybuilders and strength athletes as a so-called 'anabolic' for muscle growth and 'nutrient partitioning.' The physiological rationale is genuine but narrow.
Classic human metabolic work (Gelfand and Barrett, forearm-perfusion studies) showed that raising insulin to physiologic levels shifts muscle into net positive protein balance — but it does so almost entirely by INHIBITING muscle-protein BREAKDOWN, not by stimulating new protein synthesis.
The most rigorous synthesis of this literature — a systematic review and meta-analysis of insulin-infusion studies (Abdulla 2016) — is blunt about this: across 25 studies, insulin did NOT significantly increase muscle-protein synthesis; it significantly reduced breakdown, improving net balance, but its effect on synthesis is permissive and depends on adequate amino-acid availability.
In plain terms, in a healthy, well-fed athlete whose own pancreas already keeps insulin in the optimal range, injecting more insulin has no demonstrated power to build additional muscle.
There is NO randomized controlled trial — none — showing that exogenous insulin increases muscle mass, strength, or athletic performance in healthy non-diabetic people.
The 'anabolic' reputation in gym culture rests on theory, anecdote, and the visual 'fullness' of glycogen and water loading, not on controlled evidence of real hypertrophy or performance gain. Against that absent benefit sits an extreme, well-documented danger.
In someone whose glucose regulation is normal, an injection of exogenous insulin can drive blood glucose dangerously low; because insulin is invisible to standard anti-doping tests and is cheap and accessible, it has become a recurring cause of severe hypoglycemia in the bodybuilding community.
The case literature is grim and consistent: bodybuilders presenting in hypoglycemic coma, with seizures, requiring repeated/continuous intravenous glucose and intensive-care support — and surreptitious insulin use is now a recognized cause of unexplained coma in young, otherwise-healthy strength athletes (Evans and Lynch's 'Insulin as a drug of abuse in body building'; Heidet 2019; Konrad 1998).
Severe hypoglycemia can cause permanent brain injury and death; the margin for error is small and the dose-response unforgiving, especially when stacked with growth hormone, post-workout carbohydrate timing, or fasting.
Beyond hypoglycemia, chronic supraphysiologic insulin promotes fat storage (the opposite of the lean look it is taken for) and, with other doping agents, contributes to the broad metabolic harms documented for performance-enhancing drug misuse.
The score reflects this split honestly: a real but narrow anti-catabolic physiology, NO controlled evidence of any muscle or performance benefit in healthy athletes, and a documented risk of lethal hypoglycemia — a low-scoring, gated, harm-reduction entry.
Insulin's legitimate role is treating diabetes under medical supervision; using it to build muscle is illicit, unproven, and can kill. It is a prescription drug, not a dietary supplement, and there is no longevity rationale here.
Insulin binds the insulin receptor on muscle and fat, triggering GLUT4 translocation and driving glucose uptake, glycogen synthesis, and amino-acid transport into cells. This nutrient-storage signal is the basis of the bodybuilding 'nutrient partitioning' theory — pushing carbohydrate and amino acids into muscle.
Insulin's main effect on muscle protein is anti-catabolic: it inhibits muscle-protein breakdown rather than strongly stimulating synthesis. Forearm and meta-analytic data show net protein balance improves chiefly because proteolysis falls — and the synthesis effect is permissive, dependent on adequate circulating amino acids.
In a non-diabetic with normal glucose regulation, injected insulin drives blood glucose down — potentially to a dangerous, life-threatening low — because the body cannot switch off the exogenous dose. The same hormone that stores glucose also promotes fat storage, working against the lean physique it is taken to build.
How Insulin (bodybuilding use) works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Tap node to isolate • Pinch to zoom • Tap edge for research
There is NO endorsed bodybuilding dose — this entry does not provide a protocol, because using insulin without diabetes can cause fatal hypoglycemia and there is no evidence it builds muscle in healthy people. For medical context only: insulin is a prescription drug dosed by a clinician for diabetes, individually titrated to blood glucose and measured in international units (IU). Any non-medical, performance-driven use is illicit and dangerous, and we deliberately give no dose, timing, or 'carb-with-insulin' scheme.
Take with food
| Form | Type |
|---|---|
| 💊None for performance use — insulin is a prescription hormone for diabetes, not a muscle-building agent, and using it without diabetes risks fatal hypoglycemia | Recommended |
| 💊Adequate dietary protein and total energy, with resistance training — the only evidence-based way to drive the anabolic signal safely | Alternative |
| 💊Post-workout carbohydrate and protein from food, which raise endogenous insulin into the optimal range without injection | Alternative |
| 💊If diabetes is the actual concern, insulin (or other glucose-lowering therapy) prescribed and monitored by a clinician | Alternative |
For a healthy athlete there is no safe or evidence-based 'form' of insulin to take for muscle. The body already releases insulin after meals; injecting more does not build extra muscle and can be lethal.
Minimum: 1 days
Optimal: 1 days
Cycling: Not required
Note: Medical insulin timing is clinician-directed against measured glucose. There is no validated performance schedule; the gym practice of pairing an insulin shot with carbohydrate is exactly the pattern that produces hypoglycemic emergencies.
Dose-response data unavailable. The current published research for Insulin (bodybuilding use) does not provide sufficient dose-specific outcome data to generate reliable dose-response curves.
Refer to the Dosage & Timing section above for recommended dose ranges based on available evidence.
Raising insulin shifts muscle into positive net protein balance, but mainly by reducing protein breakdown — not by adding synthesis. In a well-fed athlete whose own insulin is already optimal, this offers no demonstrated extra benefit.
Insulin and post-workout carbohydrate load muscle glycogen and water, producing a temporarily 'fuller' look prized in bodybuilding. This is not the same as real muscle growth and is not a proven performance benefit.
There is no randomized controlled trial showing exogenous insulin increases muscle mass, strength, or athletic performance in healthy non-diabetics. The 'anabolic' reputation rests on theory and anecdote, not controlled evidence.
Injecting insulin without diabetes can cause profound hypoglycemia — confusion, seizures, coma, permanent brain injury, and death — needing repeated intravenous glucose and intensive care. The risk is the dominant feature of the abuse literature.
Chronic supraphysiologic insulin promotes fat storage — the opposite of the lean physique it is misused to achieve — and contributes to broader metabolic harm alongside other doping agents.
Avoid entirely. There is NO controlled evidence insulin builds muscle or improves performance in healthy people, and injecting it risks fatal hypoglycemia. This is the population this harm-reduction entry is warning.
Insulin is a legitimate, life-saving prescription therapy — but it must be dosed and monitored by a clinician against measured glucose, never used as a performance 'anabolic'.
Extremely high risk of severe hypoglycemia. These combinations feature repeatedly in fatal and near-fatal cases; do not use insulin non-medically at all.
Treat sudden confusion, sweating, seizures, or loss of consciousness in someone who may use insulin as a hypoglycemic emergency: call emergency services immediately and give fast carbohydrate if the person is conscious and able to swallow.
Frequently stacked in bodybuilding; growth hormone and the resulting metabolic state can compound the unpredictability of glucose handling, raising the risk of severe hypoglycemia and broad metabolic harm.
Alcohol suppresses the liver's ability to release glucose, dramatically deepening and prolonging insulin-induced hypoglycemia — a common contributor to fatal cases.
Tip: In a non-diabetic this is the central, potentially LETHAL risk — not a manageable nuisance. There is no safe self-administered performance dose. Suspected insulin-induced hypoglycemia is a medical emergency requiring immediate intravenous glucose (and often glucagon) and intensive-care monitoring; oral sugar alone is frequently insufficient.
Tip: Glucose can fall again after initial correction (especially with longer-acting insulin), so monitoring must continue for hours — a key reason these cases need hospital care, not self-management.
Tip: Chronic supraphysiologic insulin promotes fat storage — the opposite of the intended lean look. No mitigation makes non-medical use worthwhile given the danger.
Tip: Repeated subcutaneous injection causes local fat lumps and skin changes; rotating sites helps but does not address the core hypoglycemia danger.
Timing is flexible for Insulin (bodybuilding use) — consistent daily use matters more than the time of day. There is no validated performance timing — and the popular 'inject insulin then load carbohydrate' practice is precisely what drives hypoglycemic emergencies when carbohydrate intake is mistimed or insufficient.
Insulin (bodybuilding use) should be used with caution — talk to a healthcare provider before taking it. The most commonly reported side effects are severe hypoglycemia (confusion, seizures, coma, brain injury, death), hypoglycemia unawareness / rebound, fat gain. Use caution if any of these apply to you: Any non-medical / performance use by a non-diabetic — injecting insulin without diabetes can cause fatal hypoglycemia and is not a supplement use; Use without a prescription or without medical supervision; Existing hypoglycemia or hypoglycemia unawareness.
Semaglutide
Mostly mechanism / observationalAn FDA-approved GLP-1 receptor agonist (Ozempic/Rybelsus for type 2 diabetes, Wegovy for chronic weight management) with genuinely strong, large-RCT evidence for glycemic control and substantial weight loss, plus a cardiovascular-outcomes benefit. Honest appraisal: this is a real prescription medicine with real efficacy AND real risks — a boxed warning for thyroid C-cell tumors, pancreatitis and gallbladder risk, very common GI side effects, and growing concern about grey-market/compounded versions. It is included here for reference only, not as a supplement and not auto-recommended.
Polypharmacy is the norm in this setting and compounds metabolic and cardiovascular harm; it also makes any single agent's effects harder to manage and emergencies harder to interpret.
Additive glucose lowering can produce profound, hard-to-reverse hypoglycemia.